Jump to:
loading...| Preferred Name |
Saxagliptin |
|
| Synonyms |
|
|
| Definitions |
A potent, selective and competitive, cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C75983 |
|
| CAS_Registry |
945667-22-1 |
|
| Chemical_Formula |
C18H25N3O2.H2O |
|
| code |
C75983 |
|
| Contributing_Source |
FDA |
|
| definition |
A potent, selective and competitive, cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite. |
|
| FDA_UNII_Code |
9GB927LAJW |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Saxagliptin |
|
| Legacy Concept Name |
Saxagliptin |
|
| NSC Number |
760407 |
|
| Preferred_Name |
Saxagliptin |
|
| prefixIRI |
NCIT:C75983 |
|
| prefLabel |
Saxagliptin |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1611934 |
|
| subClassOf |
Create mapping